Use- and re-use of orthopedic implants in developing countries

R. Magetsari, C.R. Hilmy, J.R. van Horn, Henk J. Busscher*, G.J. Verkerke, H.C. van der Mei

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

4 Citations (Scopus)

Abstract

The use of biomaterials implants has become an integral part of modern healthcare in the Western world. Modern healthcare could not even exist without biomaterials. Organ replacement in kidney failure or the restoration of function after oncological surgery (e.g., voice prostheses and limb-saving surgery), trauma (fractures), or due to advanced age (osteoarthritis) would be impossible. The costs of these, however, are enormous. Healthcare spending and follow-up costs exceed U.S. $300 billion dollars in the United States per year and represent between 7 and 8% of total worldwide healthcare spending,1 while the spending pro capita in the United States is U.S. $3724, in Japan U.S. $1759, and in France U.S. $2,215.2 Many healthcare systems in the Western world struggle with these costs, especially in light of the danger of biomaterial-centered infections3 and with the average life expectancy approaching 80 years.

Original languageEnglish
Pages (from-to)249-250
Number of pages2
JournalJournal of Biomedical Materials Research. Part B: Applied Biomaterials
Volume69
Issue number2
DOIs
Publication statusPublished - 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'Use- and re-use of orthopedic implants in developing countries'. Together they form a unique fingerprint.

Cite this